The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders
- PMID: 30223503
- PMCID: PMC6164295
- DOI: 10.3390/ht7030028
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders
Abstract
Submicroscopic chromosomal copy number variations (CNVs), such as deletions and duplications, account for about 15⁻20% of patients affected with developmental delay, intellectual disability, multiple congenital anomalies, and autism spectrum disorder. Most of CNVs are de novo or inherited rearrangements with clinical relevance, but there are also rare inherited imbalances with unknown significance that make difficult the clinical management and genetic counselling. Chromosomal microarrays analysis (CMA) are recognized as the first-line test for CNV detection and are now routinely used in the clinical diagnostic laboratory. The recent use of CMA platforms that combine classic copy number analysis with single-nucleotide polymorphism (SNP) genotyping has increased the diagnostic yields. Here we discuss the application of the Cytoscan high-density (HD) SNP-array for the detection of CNVs. We provide an overview of molecular analyses involved in identifying pathogenic CNVs and highlight important guidelines to establish pathogenicity of CNV.
Keywords: SNP-array; copy number variations; neurodevelopmental disorders.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.Sci Rep. 2024 Feb 14;14(1):3762. doi: 10.1038/s41598-024-54385-2. Sci Rep. 2024. PMID: 38355898 Free PMC article.
-
Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.Sci Rep. 2019 Nov 28;9(1):17776. doi: 10.1038/s41598-019-54347-z. Sci Rep. 2019. PMID: 31780800 Free PMC article.
-
Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.Eur J Paediatr Neurol. 2013 Nov;17(6):589-99. doi: 10.1016/j.ejpn.2013.04.010. Epub 2013 May 24. Eur J Paediatr Neurol. 2013. PMID: 23711909
-
Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.J Pediatr Genet. 2017 Mar;6(1):42-50. doi: 10.1055/s-0036-1584306. Epub 2016 May 30. J Pediatr Genet. 2017. PMID: 28180026 Free PMC article. Review.
-
Pathogenic or not? Assessing the clinical relevance of copy number variants.Clin Genet. 2013 Nov;84(5):415-21. doi: 10.1111/cge.12242. Epub 2013 Aug 21. Clin Genet. 2013. PMID: 23895381 Review.
Cited by
-
Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies.Eur J Hum Genet. 2023 Jun;31(6):654-662. doi: 10.1038/s41431-023-01312-0. Epub 2023 Feb 13. Eur J Hum Genet. 2023. PMID: 36781956 Free PMC article.
-
Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.Haematologica. 2022 Sep 1;107(9):2081-2095. doi: 10.3324/haematol.2021.280116. Haematologica. 2022. PMID: 35295078 Free PMC article.
-
Detection of Copy Number Variants by Short Multiply Aggregated Sequence Homologies.J Mol Diagn. 2020 Dec;22(12):1476-1481. doi: 10.1016/j.jmoldx.2020.09.009. Epub 2020 Oct 23. J Mol Diagn. 2020. PMID: 33132082 Free PMC article.
-
Copy number variations across the blood-brain barrier in multiple sclerosis.Ann Clin Transl Neurol. 2022 Jul;9(7):962-976. doi: 10.1002/acn3.51573. Epub 2022 May 13. Ann Clin Transl Neurol. 2022. PMID: 35560551 Free PMC article.
-
Genome-wide CNV analysis uncovers novel pathogenic regions in cohort of five multiplex families with neurodevelopmental disorders.Heliyon. 2023 Sep 1;9(9):e19718. doi: 10.1016/j.heliyon.2023.e19718. eCollection 2023 Sep. Heliyon. 2023. PMID: 37810058 Free PMC article.
References
-
- Miller D.T., Adam M.P., Aradhya S., Biesecker L.G., Brothman A.R., Carter N.P., Church D.M., Crolla J.A., Eichler E.E., Epstein C.J., et al. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 2010;86:749–764. doi: 10.1016/j.ajhg.2010.04.006. - DOI - PMC - PubMed
-
- American Academy of Neurology Evidence Repot: Genetic and Metabolic Testing in Children with Global Developmental Delay. [(accessed on 10 July 2018)]; Available online: https://www.aan.com/Guidelines/home/GuidelineDetail/487.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources